Long Bridge Medical Receives Clearance from FDA to Initiate U.S. Pivotal Clinical Study for LensOne Prosthetic Capsular Bag
Long Bridge Medical, Inc. today announced that the U.S. Food and Drug Administration (FDA) has cleared initiation of its Investigational Device Exemption (IDE) study for LensOne™, the company's prosthetic capsular bag designed to enable reliable secondary intraocular lens (IOL) fixation in patients with absent or compromised lens capsule support in eyes that are poor candidates for anterior chamber intraocular lenses (ACIOL).
